| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/AJPCELL.00173.2004 |
| P698 | PubMed publication ID | 15201141 |
| P50 | author | Bernhard E Flucher | Q42387727 |
| Kristen O'Connell | Q73300470 | ||
| P2093 | author name string | Paul D Allen | |
| Manfred Grabner | |||
| Robert T Dirksen | |||
| Regina G Weiss | |||
| P433 | issue | 4 | |
| P921 | main subject | malignant hyperthermia | Q1585081 |
| P304 | page(s) | C1094-102 | |
| P577 | publication date | 2004-06-16 | |
| P1433 | published in | American Journal of Physiology - Cell Physiology | Q2227080 |
| P1476 | title | Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling | |
| P478 | volume | 287 |
| Q26766447 | 3D Structure of the Dihydropyridine Receptor of Skeletal Muscle |
| Q37260318 | A CaV1.1 Ca2+ channel splice variant with high conductance and voltage-sensitivity alters EC coupling in developing skeletal muscle |
| Q42667282 | A probable role of dihydropyridine receptors in repression of Ca2+ sparks demonstrated in cultured mammalian muscle |
| Q28511309 | Anesthetic- and heat-induced sudden death in calsequestrin-1-knockout mice |
| Q50658933 | Assessing the pathogenicity of RYR1 variants in malignant hyperthermia. |
| Q36953390 | Bridging the myoplasmic gap: recent developments in skeletal muscle excitation-contraction coupling |
| Q26866428 | Ca(V)1.1: The atypical prototypical voltage-gated Ca²⁺ channel |
| Q60912767 | Ca-activated Cl channel TMEM16A/ANO1 identified in zebrafish skeletal muscle is crucial for action potential acceleration |
| Q60708365 | Calcium Channelopathies |
| Q37605472 | Calcium-induced calcium release in skeletal muscle |
| Q28082428 | Channelopathies of skeletal muscle excitability |
| Q30008804 | Congenital myopathy results from misregulation of a muscle Ca2+ channel by mutant Stac3. |
| Q29871451 | Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility |
| Q53777541 | Crosstalk via the Sarcoplasmic Gap: The DHPR-RyR Interaction. |
| Q34187680 | Distinct effects on Ca2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1. |
| Q37267658 | Effects of inserting fluorescent proteins into the alpha1S II-III loop: insights into excitation-contraction coupling |
| Q40191570 | Elevated resting [Ca(2+)](i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR. |
| Q46308650 | Endogenous and maximal sarcoplasmic reticulum calcium content and calsequestrin expression in type I and type II human skeletal muscle fibres. |
| Q92719884 | Excitation-contraction coupling in skeletal muscle: recent progress and unanswered questions |
| Q59034021 | Exercise-induced rhabdomyolysis and stress-induced malignant hyperthermia events, association with malignant hyperthermia susceptibility, and RYR1 gene sequence variations |
| Q37034436 | Fluorescence Resonance Energy Transfer-based Structural Analysis of the Dihydropyridine Receptor α1S Subunit Reveals Conformational Differences Induced by Binding of the β1a Subunit |
| Q36436167 | Fluorescence resonance energy transfer (FRET) indicates that association with the type I ryanodine receptor (RyR1) causes reorientation of multiple cytoplasmic domains of the dihydropyridine receptor (DHPR) α(1S) subunit |
| Q46169511 | Functional and Structural Characterization of a Novel Malignant Hyperthermia-susceptible variant of DHPR-β1a subunit (CACNB1). |
| Q59882254 | Genetic epidemiology of malignant hyperthermia in the UK |
| Q39990393 | How is SR calcium release in muscle modulated by PIP(4,5)2? |
| Q34426471 | Identification and functional characterization of malignant hyperthermia mutation T1354S in the outer pore of the Cavalpha1S-subunit |
| Q34209677 | In vivo expression of G-protein beta1gamma2 dimer in adult mouse skeletal muscle alters L-type calcium current and excitation-contraction coupling. |
| Q47253099 | Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept |
| Q34252541 | Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2+ channel and the type 1 ryanodine receptor |
| Q34883560 | Malignant hyperthermia: a pharmacogenetic disorder |
| Q26799652 | Malignant hyperthermia: a review |
| Q38088716 | Minimally invasive metabolic testing for malignant hyperthermia susceptibility: a systematic review of the methodology and results |
| Q52605494 | Modulation of contractile apparatus Ca2+ sensitivity and disruption of excitation-contraction coupling by S-nitrosoglutathione in rat muscle fibres. |
| Q24532297 | Muscle channelopathies and critical points in functional and genetic studies |
| Q35756769 | Next-generation Sequencing of RYR1 and CACNA1S in Malignant Hyperthermia and Exertional Heat Illness |
| Q33778038 | Non-Ca2+-conducting Ca2+ channels in fish skeletal muscle excitation-contraction coupling |
| Q36615166 | Nonspecific sarcolemmal cation channels are critical for the pathogenesis of malignant hyperthermia |
| Q36565789 | Novel regulators of RyR Ca2+ release channels: insight into molecular changes in genetically-linked myopathies. |
| Q34880821 | Orthograde dihydropyridine receptor signal regulates ryanodine receptor passive leak |
| Q92644589 | Permeabilised skeletal muscle reveals mitochondrial deficiency in malignant hyperthermia-susceptible individuals |
| Q26781824 | PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamics |
| Q28074804 | PharmGKB summary: very important pharmacogene information for RYR1 |
| Q39052152 | Pharmacogenetics and pathophysiology of CACNA1S mutations in malignant hyperthermia |
| Q64964553 | RYR1 Sequence Variants in Myopathies: Expression and Functional Studies in Two Families. |
| Q37945102 | Reciprocal dihydropyridine and ryanodine receptor interactions in skeletal muscle activation |
| Q47343401 | Rhabdomyolysis and fluctuating asymptomatic hyperCKemia associated with CACNA1S variant |
| Q83483025 | Ryanodinopathies: RyR-Linked Muscle Diseases |
| Q90722875 | Skeletal muscle CaV1.1 channelopathies |
| Q35250678 | Special article: Future directions in malignant hyperthermia research and patient care |
| Q41536477 | The Ca2+ influx through the mammalian skeletal muscle dihydropyridine receptor is irrelevant for muscle performance. |
| Q41992939 | The alpha(1S) III-IV loop influences 1,4-dihydropyridine receptor gating but is not directly involved in excitation-contraction coupling interactions with the type 1 ryanodine receptor |
| Q34144818 | The beta 1a subunit is essential for the assembly of dihydropyridine-receptor arrays in skeletal muscle |
| Q41199019 | The mammalian skeletal muscle DHPR has larger Ca2+ conductance and is phylogenetically ancient to the early ray-finned fish sterlet (Acipenser ruthenus). |
| Q33510262 | The role of CACNA1S in predisposition to malignant hyperthermia |
| Q36222858 | The role of auxiliary dihydropyridine receptor subunits in muscle. |
| Q53306562 | [Telephone enquiries on the topic of malignant hyperthermia: Evaluation of the content and subsequent diagnostic results at the MH Center Leipzig]. |
Search more.